Indirect Treatment Comparisons of Daratumumab, Pomalidomide, and Dexamethasone Versus Daratumumab, Bortezomib, and Dexamethasone or Bortezomib and Dexamethasone in Patients with Difficult-To-Treat Relapsed/Refractory Multiple Myeloma

AuthID
 P-00X-5TX
10
Author(s)
He, JM
·
Berringer, H
·
Johnston, S
·
Mendes, J
·
Lam, A
·
Mackay, E
Document Type
Abstract
Year published
2021
Published
in BLOOD, ISSN: 0006-4971
Volume: 138
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:000835740100084
Source Identifiers
ISSN: 0006-4971
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

footer slogan

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service